Mitochondrial dysfunction and the role of the non-specialist laboratory

被引:6
作者
Hancock, MR [1 ]
机构
[1] Chelsea & Westminster Hosp, Dept Clin Chem, London SW10 9NH, England
关键词
D O I
10.1258/000456302320314467
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Each human cell contains at least 1000 mitochondria, each containing several copies of mitochondrial DNA. This DNA is tiny compared with the nuclear genome, and its structure and products have been fully elucidated. Whilst oxidative phosphorylation depends on the polypeptides encoded by mitochondrial DNA, it also requires a huge number of nuclear DNA products. Inherited deleterious mutations of mitochondrial DNA leading to inefficient oxidative phosphorylation have been described as 'mitochondrial disorders', with a variety of clinical presentations. When similar clinical presentations occur with no discernible Mutation of mitochondrial DNA, histological and biochemical evidence is required for diagnosis. The number of these laboratory-proven inherited mitochondrial disorders is growing. It is also becoming clear that mitochondrial DNA defects can be acquired, the most common cause being therapy with highly active antiretroviral therapy (HAART) for human immunodeficiency virus-1 (HIV-1) infection. Whilst definitive diagnosis of inherited or acquired mitochrondrial dysfunction requires access to specialist laboratory techniques, routine laboratories have a role to play in the initial investigation and monitoring of these conditions.
引用
收藏
页码:456 / 463
页数:8
相关论文
共 42 条
[1]   Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry [J].
Abe, K ;
Matsuo, Y ;
Kadekawa, J ;
Inoue, S ;
Yanagihara, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 162 (01) :65-68
[2]   SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME [J].
ANDERSON, S ;
BANKIER, AT ;
BARRELL, BG ;
DEBRUIJN, MHL ;
COULSON, AR ;
DROUIN, J ;
EPERON, IC ;
NIERLICH, DP ;
ROE, BA ;
SANGER, F ;
SCHREIER, PH ;
SMITH, AJH ;
STADEN, R ;
YOUNG, IG .
NATURE, 1981, 290 (5806) :457-465
[3]   Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease [J].
Artuch, R ;
Vilaseca, MA ;
Pineda, M .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (08) :837-845
[4]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[5]  
BROWN GK, 1995, BIMDG NEWSLETTER, V10, P4
[6]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[7]   Adverse effects of antiretroviral therapy [J].
Carr, A ;
Cooper, DA .
LANCET, 2000, 356 (9239) :1423-1430
[8]   Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia [J].
Carr, A ;
Morey, A ;
Mallon, P ;
Williams, D ;
Thorburn, DR .
LANCET, 2001, 357 (9266) :1412-1414
[9]  
CHANOT P, 2000, J HEPATOL, V32, P156
[10]   ACUTE RHABDOMYOLYSIS IN PATIENTS INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS [J].
CHARIOT, P ;
RUET, E ;
AUTHIER, FJ ;
LEVY, Y ;
GHERARDI, R .
NEUROLOGY, 1994, 44 (09) :1692-1696